Rhythm Biosciences begins commercial deployment of ColoSTAT
Share
Rhythm Biosciences (ASX:RHY) has entered its commercialisation era, announcing the first physician enrollment in its ColoSTAT Access Program.
Rhythm Biosciences (ASX:RHY) has entered its commercialisation era, announcing the first physician enrollment in its ColoSTAT Access Program.
